Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 Sep;7(3):228-37.
doi: 10.2174/157015909789152137.

Adenosine neuromodulation and traumatic brain injury

T A Lusardi  1
Affiliations

Adenosine neuromodulation and traumatic brain injury

T A Lusardi. Curr Neuropharmacol. 2009 Sep.

Abstract

Adenosine is a ubiquitous signaling molecule, with widespread activity across all organ systems. There is evidence that adenosine regulation is a significant factor in traumatic brain injury (TBI) onset, recovery, and outcome, and a growing body of experimental work examining the therapeutic potential of adenosine neuromodulation in the treatment of TBI. In the central nervous system (CNS), adenosine (dys)regulation has been demonstrated following TBI, and correlated to several TBI pathologies, including impaired cerebral hemodynamics, anaerobic metabolism, and inflammation. In addition to acute pathologies, adenosine function has been implicated in TBI comorbidities, such as cognitive deficits, psychiatric function, and post-traumatic epilepsy. This review presents studies in TBI as well as adenosine-related mechanisms in co-morbidities of and unfavorable outcomes resulting from TBI. While the exact role of the adenosine system following TBI remains unclear, there is increasing evidence that a thorough understanding of adenosine signaling will be critical to the development of diagnostic and therapeutic tools for the treatment of TBI.

Keywords: Adenosine deaminase; adenosine kinase; caffeine; comorbidity.; nucleoside transport; nucleotidase.

PubMed Disclaimer

Figures

Fig. (1)
Fig. (1)
Adenosine and its metabolites are active at all levels of cellular function.
Fig. (2)
Fig. (2)
Adenosine and metabolites regulated in response to TBI. Compounds in italics are exogenous drugs discussed in the text.
See this image and copyright information in PMC

References

    1. Abbott CA, Baker E, Sutherland GR, McCaughan GW. Genomic organization, exact localization, and tissue expression of the human CD26 (dipeptidyl peptidase IV) gene. Immunogenetics. 1994;40:331–338. - PubMed
    1. Abrams TW. Cyclic AMP (cAMP) Role in Learning and Memory. In: Squire LR, editor. Encyclopedia of Neuroscience. Oxford: Academic Press; 2009. pp. 265–277.
    1. Al Moutaery K, Al Deeb S, Ahmad Khan H, Tariq M. Caffeine impairs short-term neurological outcome after concussive head injury in rats. Neurosurgery. 2003;53:704–711. discussion 711-702. - PubMed
    1. Almeida T, Rodrigues RJ, de Mendonca A, Ribeiro JA, Cunha RA. Purinergic P2 receptors trigger adenosine release leading to adenosine A2A receptor activation and facilitation of long-term potentiation in rat hippocampal slices. Neuroscience. 2003;122:111–121. - PubMed
    1. Antoni FA. Molecular diversity of cyclic AMP signalling. Front. Neuroendocrinol. 2000;21:103–132. - PubMed